Sign up to save your podcasts
Or
Share The Evolution of MTM: What 2025 Tells Us About What’s Next
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Evolution of MTM: What 2025 Tells Us About What’s Next
In this episode of Insights Beyond the Counter, hosts Jon Grice and Lauren Adair discuss how MTM continues to prove its value - not just clinically, but economically.
In this conversation, we highlight a record-breaking 2025 for MTM within the Outcomes network, with 11.6M completed claims, growing pharmacist and technician engagement, and over $190M in clinical revenue generated.
But what’s most interesting isn’t just the growth, it’s the shift. We’re seeing movement beyond traditional CMRs toward adherence-driven programs, longitudinal patient engagement, and expanded clinical services like A1C and blood pressure monitoring.
Looking ahead, changes tied to CMS ratings in 2027 will bring renewed focus (and volume) to CMRs, making now the time for pharmacies to rethink workflows, staffing models, and technology investments.
The takeaway: MTM isn’t static. It’s evolving and pharmacies that plan for what’s next will be best positioned to capture both clinical and financial impact.
View all episodes
By OutcomesIn this episode of Insights Beyond the Counter, hosts Jon Grice and Lauren Adair discuss how MTM continues to prove its value - not just clinically, but economically.
In this conversation, we highlight a record-breaking 2025 for MTM within the Outcomes network, with 11.6M completed claims, growing pharmacist and technician engagement, and over $190M in clinical revenue generated.
But what’s most interesting isn’t just the growth, it’s the shift. We’re seeing movement beyond traditional CMRs toward adherence-driven programs, longitudinal patient engagement, and expanded clinical services like A1C and blood pressure monitoring.
Looking ahead, changes tied to CMS ratings in 2027 will bring renewed focus (and volume) to CMRs, making now the time for pharmacies to rethink workflows, staffing models, and technology investments.
The takeaway: MTM isn’t static. It’s evolving and pharmacies that plan for what’s next will be best positioned to capture both clinical and financial impact.